HyTdb

Ad-ATRA-2

HyT-032 | Adamantane | Published 2020.02.25

Basic Information

All-trans Retinoic acid(ATRA)
Linker
Adamantane
POICRABP2 — Cellular retinoic acid-binding protein 2(CRABP2)
Degradation PathwayUbiquitin-Proteasome Pathway
Published2020.02.25

Remarks

Chemical Identifiers

SMILESO=C(NCCOCCOCCNC(CC1(C2)C[C@@H](C3)C[C@H]2C[C@@H]3C1)=O)CO/N=C4CCC(C)(C)C(/C=C/C(C)=C/C=C/C(C)=C/C(O)=O)=C\4C
Molecular FormulaC37H47ClN6O4S
InChIInChI=1S/C37H47ClN6O4S/c1-22-23(2)49-36-33(22)34(28-4-6-29(38)7-5-28)41-30(35-43-42-24(3)44(35)36)17-31(45)39-8-10-47-12-13-48-11-9-40-32(46)21-37-18-25-14-26(19-37)16-27(15-25)20-37/h4-7,25-27,30H,8-21H2,1-3H3,(H,39,45)(H,40,46)/t25-,26+,27-,30-,37?/m0/s1
InChI KeyXWGOOEHRAWJMIT-GZQPHSLESA-N
IUPAC NameN-[2-[2-[2-[[2-(1-adamantyl)acetyl]amino]ethoxy]ethoxy]ethyl]-2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetamide
PubChem CID178203398

Basic Properties

TPSAComputing…
RingsComputing…
FSP3Computing…
Heavy Atom CountComputing…

Lipinski RO5

RO5 ViolationComputing…
MWComputing…
ClogPComputing…
HBDComputing…
HBAComputing…
RBComputing…

Hydrophobic Tag Properties

Tag Structure
Tag TypeAdamantane
Tag SMILESC1(CC2C3)CC(C2)CC3C1
Tag ClogP5.022
HydrophobicityHigh(ClopP>5)

Mechanism of Action

POI (Protein of Interest)

POI NameCellular retinoic acid-binding protein 2(CRABP2)
GeneCRABP2
UniProt IDP29373

Amino Acid Sequence

MPNFSGNWKIIRSENFEELLKVLGVNVMLRKIAVAAASKPAVEIKQEGDTFYIKTSTTVRTTEINFKVGEEFEEQTVDGRPCKSLVKWESENKMVCEQKLLKGEGPKTSWTRELTNDGELILTMTADDVVCTRVYVRE

3D Structure (/structures/AF-P29373-F1-model_v6.cif)

Loading /structures/AF-P29373-F1-model_v6.cif …

Function

Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors.

Degradation Pathway

NameUbiquitin-Proteasome Pathway
Assay MethodWB

Mechanism

The ubiquitin-proteasome pathway (UPP) constitutes the principal pathway for protein degradation in eukaryotic cells, mediating the breakdown of target proteins through ubiquitin tagging and subsequent proteasomal degradation. In an ATP-dependent manner, the ubiquitin-activating enzyme (E1) activates ubiquitin (Ub) and conjugates it to a ubiquitin-conjugating enzyme (E2). E3 ligase subsequently catalyzes the transfer of Ub to the target protein, leading to the formation of a polyubiquitin chain that completes the ubiquitination mark. The 19S regulatory particle of the 26S proteasome recognizes this ubiquitination signal and, after deubiquitination, mediates the ATP-dependent delivery of the substrate into the 20S proteasome for degradation.

Description

We also examined the involvement of the proteasome in HyT-mediated degradation. The 2 and 3-induced reductions of CRABP-2 were completely inhibited in the presence of the proteasome inhibitor MG132, suggesting that 2 and 3 induce the proteasomal degradation of CRABP-2 (Figure 4). This result clearly indicated the involvement of proteasome activity for the reduction of the target protein.

Activity Data

TypeDC50
Value<1 μM
POI NameCRABP2
Cell LineMCF-7
Cell Line IDCVCL_0031
Assay MethodWB
Reference10.3390/ph13030034

Description

We examined the protein reduction activity of 2, 3, and 4 using various cell lines. In MCF-7 cells; 2 and 3 effectively reduced the CRABP-2 protein level, whereas 4, which contained the less hydrophobic benzyl moiety, showed attenuated protein knockdown activity (Figure 3A and Figure S5). The CRABP2 reduction activity of 3 was similar to that of 1 in MCF7 cells (Figure S6).

Disease Information

DiseaseICD-11Source
Invasive breast carcinoma of no special type2C61.4Cell Line Origin
Embryonal CarcinomaXH8MB9Gene-Disease Association
Hyperlipidemia, Familial Combined, 35C80.2Gene-Disease Association
Lung Cancer2C25.ZGene-Disease Association
Breast Cancer2C6ZGene-Disease Association
Ovarian Cancer2C73.ZGene-Disease Association
Leukemia, Acute Myeloid2A60.3ZGene-Disease Association